CORDIS
EU research results

CORDIS

English EN

Low Dose Research towards Multidisciplinary Integration

Objective

The aim of DoReMi is to promote the sustainable integration of low dose risk research in Europe in order to aid the effective resolution of the key policy questions identified by the High Level Expert Group (HLEG) on Low Dose Risk Research (www.hleg.de). DoReMi provides an operational tool for the development of the proposed MELODI platform (Multidisciplinary European Low Dose Risk Re-search Initiative) consisting of major national bodies and research programmes that have long term commitment in low dose risk research in Europe. A Letter of Intent between the core members of MELODI has been signed in April 2009. During the project, new members are expected to join the Initiative.

The Joint Programme of Activities (JPA) of DoReMi includes: (i) a Joint Programme of Research (JPR) covering the issues outlined above and providing an overview of the needs for research infra-structures of pan-European interest and facilitating multilateral initiatives leading to better use and development of research infrastructures; (ii) a Joint Programme of Integration (JPI) to develop a coor-dinated European roadmap for the long term needs of the key players in Europe; and (iii) a Joint Pro-gramme for the Spreading of Excellence (JPSE), covering knowledge management, training and mo-bility and its implementation. The JPR focuses on the areas identified by the HLEG as the most prom-ising in terms of addressing/resolving the key policy questions, namely: the shape of dose response curve for cancer, individual susceptibilities and non-cancer effects. Radiation quality, tissue sensitivity and internal exposures will be addressed as cross cutting themes within the three main research areas. A substantial proportion of the JPA will be dedicated to the joint programme of research. The pro-gramme describes a multidisciplinary approach including interfaces with the broader biological toxico-logical and epidemiological communities. Strategic planning will be carried out in close collaboration with MELODI. The long term Strategic Research Agenda (SRA) will be developed by MELODI, whereas DoReMi research priorities are based on a shorter term Transitional Research Agenda (TRA), focusing on goals that are feasible to achieve within the 6 year project and areas where barriers need to be removed in order to proceed with the longer term strategic objectives.

Coordinator

SATEILYTURVAKESKUS

Address

Laippatie 4
00880 Helsinki

Finland

Activity type

Research Organisations

EU Contribution

€ 1 725 304,58

Administrative Contact

Sisko Salomaa (Prof.)

Participants (37)

Sort alphabetically

Sort by EU Contribution

Expand all

ORSZAGOS FREDERIC JOLIOT-CURIE SUGARBIOLOGIAI ES SUGAREGESZSEGUGYI KUTATO INTEZET

Hungary

EU Contribution

€ 156 972

INSTITUT DE RADIOPROTECTION ET DE SURETE NUCLEAIRE

France

EU Contribution

€ 1 078 242

HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH

Germany

EU Contribution

€ 1 350 597,50

COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES

France

EU Contribution

€ 1 368 340,74

Public Health England an Executive Agency of the Dept of Health

United Kingdom

EU Contribution

€ 127 658

UNIVERSITA DEGLI STUDI DI PAVIA

Italy

EU Contribution

€ 1 054 962

ISTITUTO SUPERIORE DI SANITA

Italy

EU Contribution

€ 262 198,40

STUDIECENTRUM VOOR KERNENERGIE / CENTRE D'ETUDE DE L'ENERGIE NUCLEAIRE

Belgium

EU Contribution

€ 575 477,81

BUNDESAMT FUER STRAHLENSCHUTZ

Germany

EU Contribution

€ 501 274,36

STOCKHOLMS UNIVERSITET

Sweden

EU Contribution

€ 694 194,20

FUNDACIO CENTRE DE RECERCA EN EPIDEMIOLOGIA AMBIENTAL - CREAL

Spain

EU Contribution

€ 269 925,70

INSTITUT CURIE

France

EU Contribution

€ 232 602

UNIVERSITATSKLINIKUM ERLANGEN

Germany

EU Contribution

€ 127 700

JOHANN WOLFGANG GOETHE-UNIVERSITATFRANKFURT AM MAIN

Germany

EU Contribution

€ 123 600

UNIVERSITAET ROSTOCK

Germany

EU Contribution

€ 103 800

NORGES MILJO-OG BIOVITENSKAPLIGE UNIVERSITET

Norway

DIREKTORATET FOR STRALEVERN OG ATOMSIKKERHET

Norway

FOLKEHELSEINSTITUTTET

Norway

AGENZIA NAZIONALE PER LE NUOVE TECNOLOGIE, L'ENERGIA E LO SVILUPPO ECONOMICO SOSTENIBILE

Italy

EU Contribution

€ 303 913

INSTITUTE FOR ENVIRONMENTAL SCIENCES KOUEKI ZAIDAN HOUJIN

Japan

INSTITIUID TEICNEOLAIOCHTA BHAILE ATHA CLIATH

Ireland

EU Contribution

€ 354 318,07

ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM

Netherlands

EU Contribution

€ 319 700

OXFORD BROOKES UNIVERSITY

United Kingdom

EU Contribution

€ 397 227,74

BRUNEL UNIVERSITY LONDON

United Kingdom

EU Contribution

€ 90 873

NEMZETI NEPEGESZSEGUGYI KOZPONT

Hungary

STATNI USTAV RADIACNI OCHRANY v.v.i.

Czechia

EU Contribution

€ 62 828

NUVIA LIMITED

United Kingdom

EU Contribution

€ 86 387

AWE PLC

United Kingdom

EU Contribution

€ 71 561,30

UNIVERSITAT DES SAARLANDES

Germany

EU Contribution

€ 189 999,60

ACADEMISCH ZIEKENHUIS LEIDEN

Netherlands

EU Contribution

€ 299 808

UNIVERSITAET DER BUNDESWEHR MUENCHEN

Germany

EU Contribution

€ 210 294

LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN

Germany

EU Contribution

€ 90 040

SOFIA UNIVERSITY ST KLIMENT OHRIDSKI

Bulgaria

EU Contribution

€ 206 820

INSTYTUT MEDYCYNY PRACY IMIENIA PROF. DRA MED. JERZEGO NOFERA W LODZI

Poland

EU Contribution

€ 36 390

WOJSKOWY INSTYTUT HIGIENY I EPIDEMIOLOGII

Poland

EU Contribution

€ 108 406,40

UNIWERSYTET JAGIELLONSKI

Poland

EU Contribution

€ 92 559,85

Department of Health

United Kingdom

EU Contribution

€ 326 023,75

Project information

Grant agreement ID: 249689

Status

Closed project

  • Start date

    1 January 2010

  • End date

    31 December 2015

Funded under:

FP7-EURATOM-FISSION

  • Overall budget:

    € 21 427 418,97

  • EU contribution

    € 12 999 999

Coordinated by:

SATEILYTURVAKESKUS

Finland